Rank | Gene Set | Z-score |
---|---|---|
1 | aminoglycoside antibiotic metabolic process (GO:0030647) | 6.70275113 |
2 | regulation of vitamin D biosynthetic process (GO:0060556) | 6.00728020 |
3 | negative regulation of macroautophagy (GO:0016242) | 5.54864964 |
4 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 5.45771906 |
5 | detection of molecule of bacterial origin (GO:0032490) | 5.34922237 |
6 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 5.16119575 |
7 | negative regulation of interleukin-12 production (GO:0032695) | 4.99358826 |
8 | regulation of vitamin metabolic process (GO:0030656) | 4.83657687 |
9 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.69690417 |
10 | response to peptidoglycan (GO:0032494) | 4.64186879 |
11 | regulation of cytokine secretion involved in immune response (GO:0002739) | 4.58145655 |
12 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.47481098 |
13 | regulation of mononuclear cell migration (GO:0071675) | 4.39472513 |
14 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.35418566 |
15 | regulation of chronic inflammatory response (GO:0002676) | 4.29509938 |
16 | T-helper 1 type immune response (GO:0042088) | 4.21373845 |
17 | regulation of podosome assembly (GO:0071801) | 4.20375361 |
18 | positive regulation of heat generation (GO:0031652) | 4.16436702 |
19 | regulation of posttranscriptional gene silencing (GO:0060147) | 4.14054524 |
20 | regulation of gene silencing by miRNA (GO:0060964) | 4.14054524 |
21 | regulation of gene silencing by RNA (GO:0060966) | 4.14054524 |
22 | myeloid dendritic cell differentiation (GO:0043011) | 4.11575181 |
23 | ribosome assembly (GO:0042255) | 4.07580928 |
24 | regulation of chemokine biosynthetic process (GO:0045073) | 3.97690514 |
25 | paraxial mesoderm development (GO:0048339) | 3.89884811 |
26 | type I interferon signaling pathway (GO:0060337) | 3.88202935 |
27 | cellular response to type I interferon (GO:0071357) | 3.88202935 |
28 | regulation of interferon-alpha production (GO:0032647) | 3.85691327 |
29 | response to type I interferon (GO:0034340) | 3.83078859 |
30 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.82658340 |
31 | immunoglobulin mediated immune response (GO:0016064) | 3.82048433 |
32 | macrophage activation involved in immune response (GO:0002281) | 3.79724966 |
33 | negative regulation of meiosis (GO:0045835) | 3.77665847 |
34 | post-embryonic morphogenesis (GO:0009886) | 3.75723173 |
35 | regulation of helicase activity (GO:0051095) | 3.66535111 |
36 | auditory receptor cell stereocilium organization (GO:0060088) | 3.65652971 |
37 | response to protozoan (GO:0001562) | 3.63447037 |
38 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.62891589 |
39 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.58956970 |
40 | defense response to protozoan (GO:0042832) | 3.52913006 |
41 | myeloid dendritic cell activation (GO:0001773) | 3.52804699 |
42 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.48410227 |
43 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.48224190 |
44 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.45281412 |
45 | monocyte chemotaxis (GO:0002548) | 3.44250060 |
46 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.43896582 |
47 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.43896582 |
48 | modulation by symbiont of host immune response (GO:0052553) | 3.43896582 |
49 | positive regulation by symbiont of host defense response (GO:0052509) | 3.43896582 |
50 | modulation by symbiont of host defense response (GO:0052031) | 3.43896582 |
51 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.43896582 |
52 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.42374965 |
53 | detection of external biotic stimulus (GO:0098581) | 3.42356817 |
54 | phosphate ion homeostasis (GO:0055062) | 3.42153046 |
55 | trivalent inorganic anion homeostasis (GO:0072506) | 3.42153046 |
56 | germinal center formation (GO:0002467) | 3.41791461 |
57 | regulation of immunoglobulin secretion (GO:0051023) | 3.40656535 |
58 | negative regulation of androgen receptor signaling pathway (GO:0060766) | 3.37332060 |
59 | regulation of activation of Janus kinase activity (GO:0010533) | 3.33219048 |
60 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.32708846 |
61 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.32315300 |
62 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.29913745 |
63 | glycosphingolipid catabolic process (GO:0046479) | 3.28890950 |
64 | interferon-gamma secretion (GO:0072643) | 3.28625236 |
65 | dendritic cell differentiation (GO:0097028) | 3.27928593 |
66 | regulation of interleukin-12 production (GO:0032655) | 3.24633592 |
67 | cellular response to lipopolysaccharide (GO:0071222) | 3.22987660 |
68 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.22872758 |
69 | positive regulation of interferon-alpha production (GO:0032727) | 3.22327723 |
70 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.20558689 |
71 | virion attachment to host cell (GO:0019062) | 3.20339541 |
72 | adhesion of symbiont to host cell (GO:0044650) | 3.20339541 |
73 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.19871481 |
74 | positive regulation of type 2 immune response (GO:0002830) | 3.18249229 |
75 | activation of MAPKKK activity (GO:0000185) | 3.17966511 |
76 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.17060169 |
77 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.16799885 |
78 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 3.14973699 |
79 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.14855523 |
80 | proteasome assembly (GO:0043248) | 3.13924979 |
81 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.13369560 |
82 | regulation of heat generation (GO:0031650) | 3.12268996 |
83 | cellular response to molecule of bacterial origin (GO:0071219) | 3.11749338 |
84 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.10634070 |
85 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.10463094 |
86 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.08987636 |
87 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 3.07963788 |
88 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.07738277 |
89 | purine nucleobase biosynthetic process (GO:0009113) | 3.07522909 |
90 | response to muramyl dipeptide (GO:0032495) | 3.06130130 |
91 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.05272677 |
92 | detection of biotic stimulus (GO:0009595) | 3.04942944 |
93 | cellular response to interferon-gamma (GO:0071346) | 3.03683264 |
94 | glycolipid catabolic process (GO:0019377) | 3.02630810 |
95 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.02518884 |
96 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.01809460 |
97 | regulation of antigen processing and presentation (GO:0002577) | 3.01707795 |
98 | NIK/NF-kappaB signaling (GO:0038061) | 3.00912444 |
99 | positive regulation of antigen processing and presentation (GO:0002579) | 2.95526608 |
100 | regulation of T-helper cell differentiation (GO:0045622) | 2.94362174 |
101 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.93959751 |
102 | oligosaccharide catabolic process (GO:0009313) | 2.93723231 |
103 | T cell migration (GO:0072678) | 2.93155512 |
104 | nuclear pore organization (GO:0006999) | 2.92634836 |
105 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.89915730 |
106 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.89021374 |
107 | positive regulation of fatty acid transport (GO:2000193) | 2.87502045 |
108 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.87462901 |
109 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.87168865 |
110 | positive regulation of interleukin-6 production (GO:0032755) | 2.86762686 |
111 | B cell mediated immunity (GO:0019724) | 2.85998281 |
112 | response to interferon-gamma (GO:0034341) | 2.85659262 |
113 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.85546863 |
114 | neutrophil activation involved in immune response (GO:0002283) | 2.85537036 |
115 | adhesion of symbiont to host (GO:0044406) | 2.83904115 |
116 | negative regulation of glial cell proliferation (GO:0060253) | 2.83427692 |
117 | negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518) | 2.83183127 |
118 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.81850354 |
119 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.81537337 |
120 | tRNA methylation (GO:0030488) | 2.80864490 |
121 | negative regulation of response to extracellular stimulus (GO:0032105) | 2.79547478 |
122 | negative regulation of response to nutrient levels (GO:0032108) | 2.79547478 |
123 | positive regulation of interleukin-12 production (GO:0032735) | 2.77721039 |
124 | lung epithelium development (GO:0060428) | 2.77336805 |
125 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.76792586 |
126 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.76529166 |
127 | regulation of NF-kappaB import into nucleus (GO:0042345) | 2.75927629 |
128 | skeletal muscle tissue regeneration (GO:0043403) | 2.75382799 |
129 | negative regulation of lipid storage (GO:0010888) | 2.75308741 |
130 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.74371979 |
131 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.73526296 |
132 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254) | 2.73241987 |
133 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.73072233 |
134 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.72130488 |
135 | ventricular trabecula myocardium morphogenesis (GO:0003222) | 2.72021321 |
136 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.71209253 |
137 | ribosome biogenesis (GO:0042254) | 2.71093634 |
138 | cellular response to biotic stimulus (GO:0071216) | 2.70830704 |
139 | mature B cell differentiation involved in immune response (GO:0002313) | 2.70698316 |
140 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.70650488 |
141 | regulation of macrophage chemotaxis (GO:0010758) | 2.70522204 |
142 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.70286783 |
143 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.69709573 |
144 | oxygen transport (GO:0015671) | 2.69152239 |
145 | regulation of fever generation (GO:0031620) | 2.68512756 |
146 | nucleobase biosynthetic process (GO:0046112) | 2.67987025 |
147 | lung-associated mesenchyme development (GO:0060484) | 2.67090067 |
148 | pore complex assembly (GO:0046931) | 2.66365338 |
149 | histone arginine methylation (GO:0034969) | 2.65503303 |
150 | sulfate transport (GO:0008272) | 2.65167522 |
151 | rRNA modification (GO:0000154) | 2.60135308 |
152 | mesenchyme morphogenesis (GO:0072132) | 2.60039346 |
153 | regulation of transcription from RNA polymerase II promoter involved in heart development (GO:190121 | 2.57997004 |
154 | sulfate transmembrane transport (GO:1902358) | 2.57458648 |
155 | lateral ventricle development (GO:0021670) | 2.57148088 |
156 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.55990975 |
157 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.54405983 |
158 | DNA replication checkpoint (GO:0000076) | 2.52318678 |
159 | single strand break repair (GO:0000012) | 2.51537293 |
160 | cellular anion homeostasis (GO:0030002) | 2.51253709 |
161 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.50834132 |
162 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.50834132 |
163 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.49054412 |
164 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.49054412 |
165 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.49054412 |
166 | ganglion development (GO:0061548) | 2.48180947 |
167 | regulation of hippo signaling (GO:0035330) | 2.47470296 |
168 | cell surface receptor signaling pathway involved in heart development (GO:0061311) | 2.46261027 |
169 | regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253) | 2.45431422 |
170 | trabecula morphogenesis (GO:0061383) | 2.44147095 |
171 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.43376147 |
172 | mitotic metaphase plate congression (GO:0007080) | 2.42270189 |
173 | intestinal epithelial cell development (GO:0060576) | 2.41490596 |
174 | regulation of G0 to G1 transition (GO:0070316) | 2.41140103 |
175 | sequestering of actin monomers (GO:0042989) | 2.39759838 |
176 | positive regulation of developmental pigmentation (GO:0048087) | 2.38810309 |
177 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class | 2.38535616 |
178 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.38100634 |
179 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.38100634 |
180 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.37096281 |
181 | positive regulation of protein homooligomerization (GO:0032464) | 2.37059186 |
182 | notochord development (GO:0030903) | 2.35326366 |
183 | neuron fate commitment (GO:0048663) | 2.33506206 |
184 | positive regulation of prostaglandin secretion (GO:0032308) | 2.31973851 |
185 | positive regulation of granulocyte chemotaxis (GO:0071624) | 2.30974532 |
186 | heart trabecula morphogenesis (GO:0061384) | 2.30946054 |
187 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.30760752 |
188 | negative regulation of ligase activity (GO:0051352) | 2.30760752 |
189 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 2.30643124 |
190 | histone H4-K12 acetylation (GO:0043983) | 2.30158512 |
191 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.29975037 |
192 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.29975037 |
193 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.27259803 |
194 | polyketide metabolic process (GO:0030638) | 11.1373289 |
195 | doxorubicin metabolic process (GO:0044598) | 11.1373289 |
196 | daunorubicin metabolic process (GO:0044597) | 11.1373289 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.67900500 |
2 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 5.22762784 |
3 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 5.22762784 |
4 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 5.22762784 |
5 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.19142724 |
6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.11840766 |
7 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 4.03884294 |
8 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.82117736 |
9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.63550816 |
10 | * NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 3.63399582 |
11 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.58737812 |
12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.43308530 |
13 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 3.29715451 |
14 | * SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 3.27082683 |
15 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.21857279 |
16 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 3.18427875 |
17 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.18060217 |
18 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.09781997 |
19 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.03908332 |
20 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 3.01573594 |
21 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 2.96391750 |
22 | * NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 2.95733369 |
23 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 2.95427270 |
24 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 2.85331745 |
25 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.77122378 |
26 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.76848824 |
27 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.74279278 |
28 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.69194316 |
29 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.65722793 |
30 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.61805935 |
31 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.61486265 |
32 | * POU5F1_16153702_ChIP-ChIP_HESCs_Human | 2.61054534 |
33 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.58321395 |
34 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.48628916 |
35 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.46674787 |
36 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 2.44148539 |
37 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 2.42495081 |
38 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.38763770 |
39 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.31760520 |
40 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 2.28657585 |
41 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.24394988 |
42 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 2.15447827 |
43 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.13230580 |
44 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.11161219 |
45 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 2.10154710 |
46 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.08570454 |
47 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 2.07906870 |
48 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 2.05073199 |
49 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.03960121 |
50 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 2.01886125 |
51 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.00488714 |
52 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.98551243 |
53 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.96391339 |
54 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.95125312 |
55 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.93060881 |
56 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.92218947 |
57 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.90655463 |
58 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.85118374 |
59 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.81942790 |
60 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.75504837 |
61 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.74865079 |
62 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.70846924 |
63 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.70191320 |
64 | SPI1_23127762_ChIP-Seq_K562_Human | 1.67243304 |
65 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.67168824 |
66 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.66292257 |
67 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.65294807 |
68 | MYC_22102868_ChIP-Seq_BL_Human | 1.64522993 |
69 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.64485705 |
70 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.63596537 |
71 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.61432920 |
72 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.61342393 |
73 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.61200674 |
74 | MAF_26560356_Chip-Seq_TH1_Human | 1.60728764 |
75 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.60471138 |
76 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.60265910 |
77 | KAP1_27257070_Chip-Seq_ESCs_Mouse | 1.58628085 |
78 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.56842472 |
79 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.56045601 |
80 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.56016234 |
81 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.55404353 |
82 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.52503331 |
83 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.52390279 |
84 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.52114328 |
85 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50984088 |
86 | VDR_22108803_ChIP-Seq_LS180_Human | 1.49274307 |
87 | GATA1_22025678_ChIP-Seq_K562_Human | 1.47973269 |
88 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.46757873 |
89 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.45910003 |
90 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.41051548 |
91 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.39535372 |
92 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.39213805 |
93 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.38565110 |
94 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.37632699 |
95 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.37167696 |
96 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.35891148 |
97 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.35832910 |
98 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.35247233 |
99 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33127287 |
100 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.32873040 |
101 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.32835010 |
102 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.29487475 |
103 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.29141592 |
104 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.27925107 |
105 | * NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.26885796 |
106 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.26518866 |
107 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.26417250 |
108 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.26130797 |
109 | MYB_26560356_Chip-Seq_TH2_Human | 1.25734560 |
110 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.25700075 |
111 | * NANOG_16518401_ChIP-PET_MESCs_Mouse | 1.25690642 |
112 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 1.25461148 |
113 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.23938327 |
114 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.23264692 |
115 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.22868227 |
116 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21757173 |
117 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.21171692 |
118 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.21029165 |
119 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.19833983 |
120 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.19481988 |
121 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.18570097 |
122 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.18402829 |
123 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.17639583 |
124 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16187812 |
125 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.15711373 |
126 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.15667846 |
127 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.15328125 |
128 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.14912014 |
129 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14196086 |
130 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.14173714 |
131 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14007702 |
132 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.13635480 |
133 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.12767315 |
134 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.12538652 |
135 | UTX_26944678_Chip-Seq_JUKART_Human | 1.11956579 |
136 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11724039 |
137 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.11128385 |
138 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.09673417 |
139 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.09647516 |
140 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.09577828 |
141 | MAF_26560356_Chip-Seq_TH2_Human | 1.08858192 |
142 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.08034354 |
143 | MYB_26560356_Chip-Seq_TH1_Human | 1.07632898 |
144 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.05049420 |
145 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.04660211 |
146 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.03376774 |
147 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03204084 |
148 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.99543643 |
149 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.97888716 |
150 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.97814326 |
151 | * SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.96616782 |
152 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.95111865 |
153 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.95072404 |
154 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.93768088 |
155 | GATA1_19941826_ChIP-Seq_K562_Human | 0.93399962 |
156 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92840631 |
157 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.92747635 |
158 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.92444510 |
159 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.90527448 |
160 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.90348149 |
161 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.90237016 |
162 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89995052 |
163 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.89842044 |
164 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.88536001 |
165 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.88234283 |
166 | STAT3_18555785_ChIP-Seq_MESCs_Mouse | 0.87266539 |
167 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.87076711 |
168 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.86316351 |
169 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.85566460 |
170 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.85505004 |
171 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85474739 |
172 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.84651053 |
173 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84011855 |
174 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.83949596 |
175 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.82600937 |
176 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.82014559 |
177 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.80504291 |
178 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.79868563 |
179 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.79359423 |
180 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.78757421 |
181 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.77600867 |
182 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.77500729 |
183 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.71944075 |
184 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.71894004 |
185 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.71579635 |
186 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.71510576 |
187 | RXR_22108803_ChIP-Seq_LS180_Human | 0.70415472 |
188 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.67997115 |
189 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.67825180 |
190 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.67577533 |
191 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.66888246 |
192 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.66858163 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002254_reproductive_system_inflammat | 6.46403833 |
2 | MP0003303_peritoneal_inflammation | 5.21194037 |
3 | MP0005377_hearing/vestibular/ear_phenot | 4.00849228 |
4 | MP0003878_abnormal_ear_physiology | 4.00849228 |
5 | MP0008004_abnormal_stomach_pH | 3.64092449 |
6 | MP0005058_abnormal_lysosome_morphology | 3.34349107 |
7 | MP0002277_abnormal_respiratory_mucosa | 3.33022579 |
8 | MP0003436_decreased_susceptibility_to | 3.25842309 |
9 | MP0009785_altered_susceptibility_to | 3.25478975 |
10 | MP0003941_abnormal_skin_development | 3.20993032 |
11 | MP0009840_abnormal_foam_cell | 2.83000791 |
12 | MP0005000_abnormal_immune_tolerance | 2.76600838 |
13 | MP0003724_increased_susceptibility_to | 2.69206130 |
14 | MP0001346_abnormal_lacrimal_gland | 2.67182109 |
15 | MP0005645_abnormal_hypothalamus_physiol | 2.65848668 |
16 | MP0002139_abnormal_hepatobiliary_system | 2.64834794 |
17 | MP0003300_gastrointestinal_ulcer | 2.62764382 |
18 | MP0002419_abnormal_innate_immunity | 2.40271666 |
19 | MP0005025_abnormal_response_to | 2.33748406 |
20 | MP0003136_yellow_coat_color | 2.31807326 |
21 | MP0003879_abnormal_hair_cell | 2.30495389 |
22 | MP0000343_altered_response_to | 2.28713575 |
23 | MP0009764_decreased_sensitivity_to | 2.27745280 |
24 | MP0008057_abnormal_DNA_replication | 2.18426099 |
25 | MP0002452_abnormal_antigen_presenting | 2.14751350 |
26 | MP0003075_altered_response_to | 2.13358288 |
27 | MP0002876_abnormal_thyroid_physiology | 2.12231205 |
28 | MP0003693_abnormal_embryo_hatching | 2.11229276 |
29 | MP0001800_abnormal_humoral_immune | 2.09344272 |
30 | MP0002723_abnormal_immune_serum | 2.08634962 |
31 | MP0005451_abnormal_body_composition | 2.06652099 |
32 | MP0003111_abnormal_nucleus_morphology | 2.06079324 |
33 | MP0001348_abnormal_lacrimal_gland | 2.05205602 |
34 | MP0010030_abnormal_orbit_morphology | 2.01620717 |
35 | MP0001533_abnormal_skeleton_physiology | 1.98012300 |
36 | MP0001853_heart_inflammation | 1.90835427 |
37 | MP0005503_abnormal_tendon_morphology | 1.89242008 |
38 | MP0006054_spinal_hemorrhage | 1.87660784 |
39 | MP0000685_abnormal_immune_system | 1.86713506 |
40 | MP0004947_skin_inflammation | 1.85732082 |
41 | MP0009278_abnormal_bone_marrow | 1.83680033 |
42 | MP0003172_abnormal_lysosome_physiology | 1.83665761 |
43 | MP0005171_absent_coat_pigmentation | 1.83258175 |
44 | MP0002163_abnormal_gland_morphology | 1.82831547 |
45 | MP0001485_abnormal_pinna_reflex | 1.81210191 |
46 | MP0005167_abnormal_blood-brain_barrier | 1.80334741 |
47 | MP0000678_abnormal_parathyroid_gland | 1.76131837 |
48 | MP0000604_amyloidosis | 1.72826696 |
49 | MP0001845_abnormal_inflammatory_respons | 1.72651614 |
50 | MP0002998_abnormal_bone_remodeling | 1.72523266 |
51 | MP0001986_abnormal_taste_sensitivity | 1.70342344 |
52 | MP0008438_abnormal_cutaneous_collagen | 1.69641429 |
53 | MP0001819_abnormal_immune_cell | 1.69147157 |
54 | MP0002420_abnormal_adaptive_immunity | 1.69014050 |
55 | MP0000516_abnormal_urinary_system | 1.67305527 |
56 | MP0005367_renal/urinary_system_phenotyp | 1.67305527 |
57 | MP0004133_heterotaxia | 1.66905364 |
58 | MP0004957_abnormal_blastocyst_morpholog | 1.63076890 |
59 | MP0003806_abnormal_nucleotide_metabolis | 1.62017787 |
60 | MP0010155_abnormal_intestine_physiology | 1.58801563 |
61 | MP0000566_synostosis | 1.58065089 |
62 | MP0003077_abnormal_cell_cycle | 1.57934704 |
63 | MP0006292_abnormal_olfactory_placode | 1.56926298 |
64 | MP0008469_abnormal_protein_level | 1.55107539 |
65 | MP0004510_myositis | 1.52794767 |
66 | MP0002405_respiratory_system_inflammati | 1.52359284 |
67 | MP0008007_abnormal_cellular_replicative | 1.51526722 |
68 | MP0003646_muscle_fatigue | 1.51395229 |
69 | MP0009333_abnormal_splenocyte_physiolog | 1.48732683 |
70 | MP0005397_hematopoietic_system_phenotyp | 1.44785902 |
71 | MP0001545_abnormal_hematopoietic_system | 1.44785902 |
72 | MP0009697_abnormal_copulation | 1.41685944 |
73 | MP0005310_abnormal_salivary_gland | 1.36122817 |
74 | MP0002332_abnormal_exercise_endurance | 1.33949404 |
75 | MP0001542_abnormal_bone_strength | 1.32948898 |
76 | MP0005166_decreased_susceptibility_to | 1.32133407 |
77 | MP0005275_abnormal_skin_tensile | 1.29910907 |
78 | MP0004782_abnormal_surfactant_physiolog | 1.29074103 |
79 | MP0000613_abnormal_salivary_gland | 1.28045987 |
80 | MP0008932_abnormal_embryonic_tissue | 1.27442898 |
81 | MP0005257_abnormal_intraocular_pressure | 1.25976911 |
82 | MP0003191_abnormal_cellular_cholesterol | 1.25786473 |
83 | MP0003786_premature_aging | 1.25258712 |
84 | MP0000750_abnormal_muscle_regeneration | 1.24191546 |
85 | MP0010094_abnormal_chromosome_stability | 1.23984610 |
86 | MP0000762_abnormal_tongue_morphology | 1.22466618 |
87 | MP0000716_abnormal_immune_system | 1.22270877 |
88 | MP0003718_maternal_effect | 1.22050886 |
89 | MP0008058_abnormal_DNA_repair | 1.21849903 |
90 | MP0003091_abnormal_cell_migration | 1.20436619 |
91 | MP0002877_abnormal_melanocyte_morpholog | 1.19649325 |
92 | MP0000049_abnormal_middle_ear | 1.18058173 |
93 | MP0000470_abnormal_stomach_morphology | 1.16652272 |
94 | MP0005464_abnormal_platelet_physiology | 1.15543819 |
95 | MP0002938_white_spotting | 1.15195290 |
96 | MP0003690_abnormal_glial_cell | 1.09056038 |
97 | MP0001293_anophthalmia | 1.07238836 |
98 | MP0002249_abnormal_larynx_morphology | 1.03991705 |
99 | MP0003656_abnormal_erythrocyte_physiolo | 1.03990646 |
100 | MP0002398_abnormal_bone_marrow | 1.02634406 |
101 | MP0002735_abnormal_chemical_nociception | 1.00987485 |
102 | * MP0000733_abnormal_muscle_development | 1.00105141 |
103 | MP0003195_calcinosis | 0.99881765 |
104 | MP0000371_diluted_coat_color | 0.99245748 |
105 | MP0005508_abnormal_skeleton_morphology | 0.98477013 |
106 | MP0005164_abnormal_response_to | 0.98336812 |
107 | MP0003279_aneurysm | 0.98115377 |
108 | MP0006276_abnormal_autonomic_nervous | 0.97720556 |
109 | MP0005390_skeleton_phenotype | 0.95309003 |
110 | MP0000858_altered_metastatic_potential | 0.94826448 |
111 | MP0009763_increased_sensitivity_to | 0.94793228 |
112 | MP0005165_increased_susceptibility_to | 0.94261872 |
113 | MP0002429_abnormal_blood_cell | 0.93680244 |
114 | MP0006082_CNS_inflammation | 0.92448871 |
115 | MP0001835_abnormal_antigen_presentation | 0.91900924 |
116 | MP0003566_abnormal_cell_adhesion | 0.90748098 |
117 | MP0004858_abnormal_nervous_system | 0.89860717 |
118 | MP0002148_abnormal_hypersensitivity_rea | 0.86572914 |
119 | MP0005023_abnormal_wound_healing | 0.85652482 |
120 | MP0000920_abnormal_myelination | 0.85628621 |
121 | MP0002933_joint_inflammation | 0.85296865 |
122 | MP0000689_abnormal_spleen_morphology | 0.85200505 |
123 | MP0000627_abnormal_mammary_gland | 0.84865800 |
124 | MP0004272_abnormal_basement_membrane | 0.83839328 |
125 | MP0010352_gastrointestinal_tract_polyps | 0.82355458 |
126 | MP0000350_abnormal_cell_proliferation | 0.81771502 |
127 | MP0003763_abnormal_thymus_physiology | 0.81057629 |
128 | MP0001873_stomach_inflammation | 0.80938763 |
129 | MP0003936_abnormal_reproductive_system | 0.80297871 |
130 | MP0003448_altered_tumor_morphology | 0.80192755 |
131 | MP0005623_abnormal_meninges_morphology | 0.79928064 |
132 | MP0002751_abnormal_autonomic_nervous | 0.79494629 |
133 | MP0002160_abnormal_reproductive_system | 0.77898289 |
134 | MP0005076_abnormal_cell_differentiation | 0.77669255 |
135 | MP0002108_abnormal_muscle_morphology | 0.77351808 |
136 | MP0002722_abnormal_immune_system | 0.77024344 |
137 | MP0008874_decreased_physiological_sensi | 0.76394483 |
138 | * MP0003755_abnormal_palate_morphology | 0.75854079 |
139 | MP0003795_abnormal_bone_structure | 0.75666750 |
140 | MP0009765_abnormal_xenobiotic_induced | 0.74916522 |
141 | MP0002233_abnormal_nose_morphology | 0.74903946 |
142 | MP0005647_abnormal_sex_gland | 0.74640211 |
143 | MP0001663_abnormal_digestive_system | 0.74334207 |
144 | MP0003938_abnormal_ear_development | 0.73574769 |
145 | MP0002127_abnormal_cardiovascular_syste | 0.73476796 |
146 | MP0003453_abnormal_keratinocyte_physiol | 0.73106344 |
147 | MP0003329_amyloid_beta_deposits | 0.72326124 |
148 | MP0005389_reproductive_system_phenotype | 0.71110460 |
149 | MP0005423_abnormal_somatic_nervous | 0.70527165 |
150 | MP0000534_abnormal_ureter_morphology | 0.70368006 |
151 | MP0008260_abnormal_autophagy | 0.67203768 |
152 | MP0003705_abnormal_hypodermis_morpholog | 0.67090148 |
153 | MP0002111_abnormal_tail_morphology | 0.66438969 |
154 | MP0004883_abnormal_blood_vessel | 0.65921096 |
155 | MP0005595_abnormal_vascular_smooth | 0.65838403 |
156 | MP0010307_abnormal_tumor_latency | 0.65769470 |
157 | MP0000249_abnormal_blood_vessel | 0.65359747 |
158 | MP0009250_abnormal_appendicular_skeleto | 0.64703817 |
159 | MP0003183_abnormal_peptide_metabolism | 0.63861181 |
160 | MP0004808_abnormal_hematopoietic_stem | 0.63665350 |
161 | MP0002085_abnormal_embryonic_tissue | 0.63427084 |
162 | MP0000428_abnormal_craniofacial_morphol | 0.63044787 |
163 | MP0002837_dystrophic_cardiac_calcinosis | 0.62383291 |
164 | MP0001286_abnormal_eye_development | 0.60745067 |
165 | MP0003828_pulmonary_edema | 0.60483659 |
166 | MP0000432_abnormal_head_morphology | 0.60353123 |
167 | MP0001119_abnormal_female_reproductive | 0.60187074 |
168 | MP0001790_abnormal_immune_system | 0.58894404 |
169 | MP0005387_immune_system_phenotype | 0.58894404 |
170 | MP0008789_abnormal_olfactory_epithelium | 0.58410209 |
171 | MP0003937_abnormal_limbs/digits/tail_de | 0.56910836 |
172 | MP0002138_abnormal_hepatobiliary_system | 0.56219220 |
173 | MP0003950_abnormal_plasma_membrane | 0.55831211 |
174 | MP0003119_abnormal_digestive_system | 0.55283189 |
175 | MP0001849_ear_inflammation | 0.54788869 |
176 | MP0005671_abnormal_response_to | 0.53616110 |
177 | MP0002116_abnormal_craniofacial_bone | 0.51852430 |
178 | MP0004084_abnormal_cardiac_muscle | 0.51487361 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of liposaccharide metabolism (HP:0010968) | 7.03373109 |
2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 7.03373109 |
3 | Abnormality of glycolipid metabolism (HP:0010969) | 7.03373109 |
4 | Alopecia of scalp (HP:0002293) | 6.27283973 |
5 | Unilateral renal agenesis (HP:0000122) | 5.62021361 |
6 | Type 2 muscle fiber atrophy (HP:0003554) | 5.28667003 |
7 | Systemic lupus erythematosus (HP:0002725) | 4.71714997 |
8 | Muscle fiber atrophy (HP:0100295) | 4.69287203 |
9 | Vacuolated lymphocytes (HP:0001922) | 4.62403296 |
10 | Abnormality of macrophages (HP:0004311) | 4.55020511 |
11 | Parakeratosis (HP:0001036) | 4.43932397 |
12 | Dysostosis multiplex (HP:0000943) | 4.42184233 |
13 | Follicular hyperkeratosis (HP:0007502) | 4.30325205 |
14 | Loss of speech (HP:0002371) | 4.26424617 |
15 | Increased cerebral lipofuscin (HP:0011813) | 4.26328511 |
16 | Disinhibition (HP:0000734) | 4.10766035 |
17 | Orchitis (HP:0100796) | 3.94830401 |
18 | Retrobulbar optic neuritis (HP:0100654) | 3.94319471 |
19 | Optic neuritis (HP:0100653) | 3.94319471 |
20 | Recurrent bacterial skin infections (HP:0005406) | 3.92120401 |
21 | Duplicated collecting system (HP:0000081) | 3.87547888 |
22 | Abnormality of the renal collecting system (HP:0004742) | 3.74873669 |
23 | Mediastinal lymphadenopathy (HP:0100721) | 3.70254383 |
24 | Nuclear cataract (HP:0100018) | 3.67561882 |
25 | Bilateral sensorineural hearing impairment (HP:0008619) | 3.64314452 |
26 | Autoimmune thrombocytopenia (HP:0001973) | 3.61119061 |
27 | Mutism (HP:0002300) | 3.59078851 |
28 | Recurrent abscess formation (HP:0002722) | 3.55358271 |
29 | Eczematoid dermatitis (HP:0000976) | 3.53048577 |
30 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.43367517 |
31 | Myositis (HP:0100614) | 3.37354500 |
32 | Absent eyelashes (HP:0000561) | 3.36258753 |
33 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.32250392 |
34 | Cheilitis (HP:0100825) | 3.31425400 |
35 | Septo-optic dysplasia (HP:0100842) | 3.25647335 |
36 | Breast hypoplasia (HP:0003187) | 3.22556543 |
37 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.22362445 |
38 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.22362445 |
39 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.22362445 |
40 | Abnormality of dental color (HP:0011073) | 3.21820863 |
41 | Fatigable weakness (HP:0003473) | 3.21469877 |
42 | Abnormality of the neuromuscular junction (HP:0003398) | 3.21469877 |
43 | Stomatitis (HP:0010280) | 3.19492122 |
44 | Neurofibrillary tangles (HP:0002185) | 3.14444994 |
45 | Birth length less than 3rd percentile (HP:0003561) | 3.12754855 |
46 | Recurrent corneal erosions (HP:0000495) | 3.11995455 |
47 | Gastrointestinal stroma tumor (HP:0100723) | 3.10325335 |
48 | Mucopolysacchariduria (HP:0008155) | 3.03485026 |
49 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.03485026 |
50 | Glomerulonephritis (HP:0000099) | 2.99744421 |
51 | Absent eyebrow (HP:0002223) | 2.98733957 |
52 | Chromsome breakage (HP:0040012) | 2.96512483 |
53 | Axonal loss (HP:0003447) | 2.91810015 |
54 | Pulmonary infiltrates (HP:0002113) | 2.87583095 |
55 | Ureteral duplication (HP:0000073) | 2.86517150 |
56 | Muscle fiber splitting (HP:0003555) | 2.85965886 |
57 | Vasculitis (HP:0002633) | 2.84740781 |
58 | Increased serum ferritin (HP:0003281) | 2.82472827 |
59 | Increased IgM level (HP:0003496) | 2.81355252 |
60 | Absent radius (HP:0003974) | 2.80152796 |
61 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.78470940 |
62 | Apathy (HP:0000741) | 2.75935170 |
63 | Sparse eyelashes (HP:0000653) | 2.75436838 |
64 | Hyperphosphatemia (HP:0002905) | 2.69069514 |
65 | Keratoconjunctivitis sicca (HP:0001097) | 2.68687532 |
66 | Abnormality of proline metabolism (HP:0010907) | 2.68487093 |
67 | Hydroxyprolinuria (HP:0003080) | 2.68487093 |
68 | Diminished motivation (HP:0000745) | 2.66391488 |
69 | Abnormal trabecular bone morphology (HP:0100671) | 2.65107050 |
70 | Absent forearm bone (HP:0003953) | 2.62852199 |
71 | Aplasia involving forearm bones (HP:0009822) | 2.62852199 |
72 | Asplenia (HP:0001746) | 2.61111459 |
73 | Myocardial infarction (HP:0001658) | 2.61064416 |
74 | Hematochezia (HP:0002573) | 2.58907768 |
75 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.57481299 |
76 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.55749486 |
77 | IgA deficiency (HP:0002720) | 2.53445448 |
78 | Weak cry (HP:0001612) | 2.53214876 |
79 | Metaphyseal irregularity (HP:0003025) | 2.50122900 |
80 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.49809465 |
81 | Recurrent viral infections (HP:0004429) | 2.48527990 |
82 | Wrist flexion contracture (HP:0001239) | 2.46618908 |
83 | Purpura (HP:0000979) | 2.45786996 |
84 | Progressive neurologic deterioration (HP:0002344) | 2.45147210 |
85 | Cerebral inclusion bodies (HP:0100314) | 2.44105230 |
86 | Keratitis (HP:0000491) | 2.39991916 |
87 | Rough bone trabeculation (HP:0100670) | 2.39469042 |
88 | Aplasia of the musculature (HP:0100854) | 2.36644940 |
89 | Recurrent cutaneous fungal infections (HP:0011370) | 2.34927883 |
90 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.34927883 |
91 | Conical tooth (HP:0000698) | 2.34008438 |
92 | Emphysema (HP:0002097) | 2.33658253 |
93 | Petechiae (HP:0000967) | 2.32904453 |
94 | Ectopic kidney (HP:0000086) | 2.32885302 |
95 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.30677391 |
96 | Absent/shortened dynein arms (HP:0200106) | 2.30677391 |
97 | Complement deficiency (HP:0004431) | 2.30668520 |
98 | Gangrene (HP:0100758) | 2.30221340 |
99 | Hemoptysis (HP:0002105) | 2.30191863 |
100 | Patellar aplasia (HP:0006443) | 2.28268567 |
101 | Neuronal loss in central nervous system (HP:0002529) | 2.26728987 |
102 | Vertebral compression fractures (HP:0002953) | 2.25884219 |
103 | Abnormality of placental membranes (HP:0011409) | 2.24827068 |
104 | Amniotic constriction ring (HP:0009775) | 2.24827068 |
105 | Interstitial pulmonary disease (HP:0006530) | 2.24602989 |
106 | Absent hand (HP:0004050) | 2.24119719 |
107 | Difficulty climbing stairs (HP:0003551) | 2.23871092 |
108 | Restrictive lung disease (HP:0002091) | 2.21459219 |
109 | Obstructive lung disease (HP:0006536) | 2.21406623 |
110 | Chronic obstructive pulmonary disease (HP:0006510) | 2.21406623 |
111 | Meningitis (HP:0001287) | 2.21284960 |
112 | Palmar hyperkeratosis (HP:0010765) | 2.21107250 |
113 | Basal ganglia calcification (HP:0002135) | 2.20732982 |
114 | Keratoconjunctivitis (HP:0001096) | 2.20417932 |
115 | Asymmetric septal hypertrophy (HP:0001670) | 2.18893019 |
116 | Upper motor neuron abnormality (HP:0002127) | 2.18308666 |
117 | Right ventricular cardiomyopathy (HP:0011663) | 2.17710104 |
118 | Breast aplasia (HP:0100783) | 2.17603517 |
119 | Nausea (HP:0002018) | 2.17388549 |
120 | Hepatosplenomegaly (HP:0001433) | 2.16860674 |
121 | Inappropriate behavior (HP:0000719) | 2.16137568 |
122 | Polyneuropathy (HP:0001271) | 2.15897620 |
123 | Cerebral hypomyelination (HP:0006808) | 2.15701869 |
124 | Ankle contracture (HP:0006466) | 2.15026157 |
125 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.14124247 |
126 | Recurrent skin infections (HP:0001581) | 2.14010588 |
127 | Upper limb muscle weakness (HP:0003484) | 2.13508710 |
128 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.12788973 |
129 | Palmoplantar hyperkeratosis (HP:0000972) | 2.12526174 |
130 | Thin bony cortex (HP:0002753) | 2.12272898 |
131 | Easy fatigability (HP:0003388) | 2.11323070 |
132 | Abnormality of iron homeostasis (HP:0011031) | 2.11123253 |
133 | Spondylolisthesis (HP:0003302) | 2.10415538 |
134 | Hypergammaglobulinemia (HP:0010702) | 2.10050820 |
135 | Aplasia/Hypoplasia of the breasts (HP:0010311) | 2.08482437 |
136 | Amyloidosis (HP:0011034) | 2.08319657 |
137 | Distal lower limb amyotrophy (HP:0008944) | 2.07399086 |
138 | Rhabdomyosarcoma (HP:0002859) | 2.06135930 |
139 | Prostate neoplasm (HP:0100787) | 2.03603172 |
140 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.03219326 |
141 | Personality changes (HP:0000751) | 2.03139939 |
142 | Agnosia (HP:0010524) | 2.02794509 |
143 | Prolonged neonatal jaundice (HP:0006579) | 2.01900514 |
144 | Hypohidrosis (HP:0000966) | 2.01845884 |
145 | Arthralgia (HP:0002829) | 2.01337261 |
146 | Blepharitis (HP:0000498) | 2.01260828 |
147 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.01163792 |
148 | Plantar hyperkeratosis (HP:0007556) | 2.00380115 |
149 | Recurrent fungal infections (HP:0002841) | 2.00159006 |
150 | Autoimmune hemolytic anemia (HP:0001890) | 1.99827448 |
151 | Premature rupture of membranes (HP:0001788) | 1.99689633 |
152 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.99365517 |
153 | Abnormality of complement system (HP:0005339) | 1.98989893 |
154 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.94876004 |
155 | Hypertensive crisis (HP:0100735) | 1.93612042 |
156 | Dementia (HP:0000726) | 1.92121782 |
157 | Neoplasm of the respiratory system (HP:0100606) | 1.90948791 |
158 | Erythroderma (HP:0001019) | 1.90286999 |
159 | Increased connective tissue (HP:0009025) | 1.90045758 |
160 | Nail dystrophy (HP:0008404) | 1.89078794 |
161 | Distal lower limb muscle weakness (HP:0009053) | 1.89060313 |
162 | Urticaria (HP:0001025) | 1.88910446 |
163 | Abnormality of the nasal mucosa (HP:0000433) | 1.87988117 |
164 | Abnormality of the pleura (HP:0002103) | 1.87840466 |
165 | Maternal diabetes (HP:0009800) | 1.86134351 |
166 | Ectropion (HP:0000656) | 1.85722591 |
167 | Malnutrition (HP:0004395) | 1.85175657 |
168 | Arterial thrombosis (HP:0004420) | 1.85153027 |
169 | Lymphopenia (HP:0001888) | 1.85142029 |
170 | Bone pain (HP:0002653) | 1.84535017 |
171 | T lymphocytopenia (HP:0005403) | 1.84224841 |
172 | Acrocyanosis (HP:0001063) | 1.84169932 |
173 | Popliteal pterygium (HP:0009756) | 1.83646512 |
174 | Pelvic girdle muscle weakness (HP:0003749) | 1.83645809 |
175 | Memory impairment (HP:0002354) | 1.83396129 |
176 | Cellulitis (HP:0100658) | 1.82519219 |
177 | Absent septum pellucidum (HP:0001331) | 1.82453973 |
178 | Increased IgE level (HP:0003212) | 1.81771527 |
179 | Malignant hyperthermia (HP:0002047) | 1.81713232 |
180 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.81108313 |
181 | Adrenal hypoplasia (HP:0000835) | 1.80940406 |
182 | Selective tooth agenesis (HP:0001592) | 1.79453879 |
183 | Amaurosis fugax (HP:0100576) | 1.77103516 |
184 | Tongue fasciculations (HP:0001308) | 1.76669177 |
185 | Abnormality of the septum pellucidum (HP:0007375) | 1.76199305 |
186 | Hypoparathyroidism (HP:0000829) | 1.75893178 |
187 | Meckel diverticulum (HP:0002245) | 1.75882930 |
188 | Chronic otitis media (HP:0000389) | 1.75445072 |
189 | Trismus (HP:0000211) | 1.74396377 |
190 | Ependymoma (HP:0002888) | 1.73132022 |
191 | Shoulder girdle muscle weakness (HP:0003547) | 1.72578501 |
192 | Hypergonadotropic hypogonadism (HP:0000815) | 1.72173519 |
193 | Congenital, generalized hypertrichosis (HP:0004540) | 1.71800131 |
194 | Abnormality of the labia minora (HP:0012880) | 1.71012030 |
195 | Neoplasm of the lung (HP:0100526) | 1.69991113 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EPHA2 | 5.91666436 |
2 | SIK3 | 5.82130316 |
3 | BUB1 | 4.81832902 |
4 | TSSK6 | 3.16350537 |
5 | TBK1 | 2.85977595 |
6 | MATK | 2.77347334 |
7 | AKT3 | 2.69977026 |
8 | ZAK | 2.61627727 |
9 | MAP3K14 | 2.52006351 |
10 | WEE1 | 2.51854419 |
11 | RIPK4 | 2.49174099 |
12 | FGFR4 | 2.31853545 |
13 | SIK2 | 2.16503074 |
14 | STK38L | 2.14167649 |
15 | MAP4K1 | 2.09956237 |
16 | BLK | 2.07251493 |
17 | TYK2 | 2.04091346 |
18 | FGR | 2.03305090 |
19 | PRPF4B | 2.00121410 |
20 | IKBKE | 1.93317052 |
21 | TGFBR2 | 1.81489866 |
22 | ERN1 | 1.81168598 |
23 | SIK1 | 1.80103534 |
24 | PAK4 | 1.78241799 |
25 | MAP3K3 | 1.71726219 |
26 | EPHA3 | 1.67142419 |
27 | CSK | 1.66789236 |
28 | MARK3 | 1.64576560 |
29 | TAOK1 | 1.63268247 |
30 | RIPK1 | 1.57322890 |
31 | CDK8 | 1.53859032 |
32 | SRPK1 | 1.40600038 |
33 | DYRK3 | 1.33232198 |
34 | TAOK2 | 1.29334306 |
35 | BMPR1B | 1.27322297 |
36 | ERBB3 | 1.27138270 |
37 | MAP3K13 | 1.26508758 |
38 | EIF2AK1 | 1.26244038 |
39 | MUSK | 1.23812664 |
40 | CDK12 | 1.21926369 |
41 | ABL2 | 1.21734245 |
42 | JAK1 | 1.19126465 |
43 | STK16 | 1.17212821 |
44 | PLK3 | 1.15873125 |
45 | IRAK3 | 1.13169864 |
46 | PDGFRA | 1.12485664 |
47 | MAP2K3 | 1.11792358 |
48 | EIF2AK2 | 1.11313682 |
49 | NEK9 | 1.10089153 |
50 | NME1 | 1.09023823 |
51 | TTK | 1.08468356 |
52 | TYRO3 | 1.07459626 |
53 | BMPR2 | 1.06486736 |
54 | BCR | 1.05304977 |
55 | ACVR1B | 1.04501396 |
56 | PIM2 | 1.02272604 |
57 | DYRK2 | 1.01782065 |
58 | VRK1 | 0.99767481 |
59 | IRAK1 | 0.98101296 |
60 | CSF1R | 0.96515970 |
61 | RPS6KB2 | 0.96182948 |
62 | SYK | 0.95480977 |
63 | LYN | 0.94190731 |
64 | LATS1 | 0.92634406 |
65 | CHUK | 0.88549050 |
66 | GRK5 | 0.87560356 |
67 | PLK1 | 0.87532755 |
68 | MAP3K5 | 0.87063366 |
69 | PLK4 | 0.86009530 |
70 | MOS | 0.83947565 |
71 | MARK1 | 0.83525959 |
72 | MAP3K1 | 0.83273704 |
73 | PNCK | 0.83072128 |
74 | KIT | 0.82483926 |
75 | CDK7 | 0.81030785 |
76 | IRAK4 | 0.80029081 |
77 | MKNK2 | 0.79222629 |
78 | TESK1 | 0.79213792 |
79 | MST4 | 0.78939663 |
80 | IKBKB | 0.78871631 |
81 | ZAP70 | 0.77296594 |
82 | NEK2 | 0.76478601 |
83 | BRAF | 0.76048998 |
84 | CLK1 | 0.74492956 |
85 | NLK | 0.72571030 |
86 | FER | 0.71315305 |
87 | STK10 | 0.70741951 |
88 | DDR2 | 0.69498090 |
89 | MELK | 0.67955793 |
90 | CHEK2 | 0.65608046 |
91 | DAPK3 | 0.64285819 |
92 | MKNK1 | 0.63719981 |
93 | TGFBR1 | 0.63579624 |
94 | BRSK2 | 0.63189336 |
95 | OBSCN | 0.63188153 |
96 | JAK2 | 0.62219888 |
97 | LATS2 | 0.62067127 |
98 | TLK1 | 0.58311652 |
99 | PIM1 | 0.58199319 |
100 | YES1 | 0.57531237 |
101 | MAPK4 | 0.57322334 |
102 | ATR | 0.56266676 |
103 | ALK | 0.56087162 |
104 | LCK | 0.54599988 |
105 | STK24 | 0.52072393 |
106 | ADRBK2 | 0.51411392 |
107 | FGFR3 | 0.50794806 |
108 | MAPKAPK3 | 0.50360811 |
109 | MAP3K11 | 0.49372382 |
110 | PINK1 | 0.47748728 |
111 | CDK6 | 0.47217912 |
112 | NEK1 | 0.45496003 |
113 | PDK2 | 0.44693882 |
114 | NME2 | 0.44493389 |
115 | RPS6KA5 | 0.44135278 |
116 | CHEK1 | 0.44078354 |
117 | PKN1 | 0.41312748 |
118 | BTK | 0.40337687 |
119 | MAPK7 | 0.40096708 |
120 | TESK2 | 0.39417158 |
121 | RPS6KC1 | 0.39374142 |
122 | RPS6KL1 | 0.39374142 |
123 | GRK7 | 0.39169520 |
124 | HCK | 0.38926217 |
125 | AKT2 | 0.38315848 |
126 | LIMK1 | 0.38050976 |
127 | ARAF | 0.36524413 |
128 | TXK | 0.36093593 |
129 | TTN | 0.34954567 |
130 | ICK | 0.34681632 |
131 | PLK2 | 0.34517975 |
132 | INSR | 0.33341977 |
133 | AURKB | 0.32829166 |
134 | CSNK2A1 | 0.32763653 |
135 | CDC42BPA | 0.32205984 |
136 | MAP2K6 | 0.31520134 |
137 | ABL1 | 0.31265145 |
138 | MAP3K8 | 0.31226286 |
139 | TRIB3 | 0.31109854 |
140 | PRKCD | 0.29701445 |
141 | AURKA | 0.29478990 |
142 | CDK4 | 0.29152469 |
143 | PDGFRB | 0.28933944 |
144 | EPHB1 | 0.28376539 |
145 | CDK15 | 0.28183748 |
146 | HIPK2 | 0.27839302 |
147 | MAPK13 | 0.27515430 |
148 | RPS6KA6 | 0.27371821 |
149 | DAPK2 | 0.26634220 |
150 | PRKCI | 0.26494029 |
151 | PAK1 | 0.26385525 |
152 | BMX | 0.26371436 |
153 | EIF2AK3 | 0.25797059 |
154 | JAK3 | 0.25745918 |
155 | CDK11A | 0.25536751 |
156 | PRKCE | 0.25516449 |
157 | CSNK1D | 0.25105404 |
158 | MAP2K2 | 0.25009297 |
159 | RPS6KA2 | 0.24968858 |
160 | IRAK2 | 0.24576230 |
161 | CDK18 | 0.24420950 |
162 | BRSK1 | 0.24389739 |
163 | CDK14 | 0.24351989 |
164 | SMG1 | 0.23846256 |
165 | MAPKAPK2 | 0.23611849 |
166 | GSK3A | 0.22371958 |
167 | MAPK11 | 0.21553865 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Proteasome_Homo sapiens_hsa03050 | 4.01297204 |
2 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.37965794 |
3 | Other glycan degradation_Homo sapiens_hsa00511 | 2.69049505 |
4 | DNA replication_Homo sapiens_hsa03030 | 2.56396776 |
5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.54619211 |
6 | RNA polymerase_Homo sapiens_hsa03020 | 2.54122628 |
7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.43229833 |
8 | Malaria_Homo sapiens_hsa05144 | 2.35350880 |
9 | Lysosome_Homo sapiens_hsa04142 | 2.33309243 |
10 | Homologous recombination_Homo sapiens_hsa03440 | 2.24648872 |
11 | RNA transport_Homo sapiens_hsa03013 | 2.21976641 |
12 | Mismatch repair_Homo sapiens_hsa03430 | 2.21001703 |
13 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.07091959 |
14 | Spliceosome_Homo sapiens_hsa03040 | 2.03488854 |
15 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.95370101 |
16 | Cell cycle_Homo sapiens_hsa04110 | 1.86861452 |
17 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.81837855 |
18 | Allograft rejection_Homo sapiens_hsa05330 | 1.79267222 |
19 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.65935595 |
20 | Base excision repair_Homo sapiens_hsa03410 | 1.62403129 |
21 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.61078165 |
22 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.60283254 |
23 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.60059039 |
24 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.59675706 |
25 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.59016775 |
26 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.58842257 |
27 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.51220243 |
28 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.49805281 |
29 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.45412203 |
30 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.43095483 |
31 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.40855742 |
32 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.40108055 |
33 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.38708243 |
34 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.37378803 |
35 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.36861940 |
36 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.34729765 |
37 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.34136056 |
38 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.33919609 |
39 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.30193285 |
40 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.29376497 |
41 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.27315967 |
42 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.26789338 |
43 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.26600163 |
44 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.23202611 |
45 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.19283315 |
46 | Legionellosis_Homo sapiens_hsa05134 | 1.15922016 |
47 | HTLV-I infection_Homo sapiens_hsa05166 | 1.10792874 |
48 | Hepatitis C_Homo sapiens_hsa05160 | 1.10678716 |
49 | Hepatitis B_Homo sapiens_hsa05161 | 1.10375918 |
50 | Asthma_Homo sapiens_hsa05310 | 1.09402786 |
51 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.07892638 |
52 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.06940045 |
53 | Basal transcription factors_Homo sapiens_hsa03022 | 1.06753820 |
54 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.06277467 |
55 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.05728125 |
56 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.04377460 |
57 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.04223100 |
58 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.02784947 |
59 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.95805606 |
60 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.95025536 |
61 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.94664411 |
62 | Ribosome_Homo sapiens_hsa03010 | 0.93976692 |
63 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.93754758 |
64 | Apoptosis_Homo sapiens_hsa04210 | 0.92990656 |
65 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.92461578 |
66 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.89882199 |
67 | Viral myocarditis_Homo sapiens_hsa05416 | 0.88184454 |
68 | Amoebiasis_Homo sapiens_hsa05146 | 0.88147400 |
69 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.87712383 |
70 | Measles_Homo sapiens_hsa05162 | 0.85763771 |
71 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.85660341 |
72 | Purine metabolism_Homo sapiens_hsa00230 | 0.83767279 |
73 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.81993877 |
74 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.80731716 |
75 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.79421161 |
76 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.77051539 |
77 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.75450128 |
78 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.75116813 |
79 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.75031562 |
80 | Adherens junction_Homo sapiens_hsa04520 | 0.74228354 |
81 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.74192216 |
82 | Leishmaniasis_Homo sapiens_hsa05140 | 0.74172528 |
83 | Melanoma_Homo sapiens_hsa05218 | 0.73269777 |
84 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.71495028 |
85 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.71365465 |
86 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.70944264 |
87 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.70821959 |
88 | Mineral absorption_Homo sapiens_hsa04978 | 0.70734462 |
89 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.70358049 |
90 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.69410909 |
91 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.69336629 |
92 | Influenza A_Homo sapiens_hsa05164 | 0.68051773 |
93 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.67709759 |
94 | Pathways in cancer_Homo sapiens_hsa05200 | 0.67466780 |
95 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.66111188 |
96 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.65979473 |
97 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.64280099 |
98 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.63747848 |
99 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.61636097 |
100 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.60079362 |
101 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.59305962 |
102 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.59244523 |
103 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.58411814 |
104 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.58335734 |
105 | Prion diseases_Homo sapiens_hsa05020 | 0.57912596 |
106 | RNA degradation_Homo sapiens_hsa03018 | 0.56980421 |
107 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.56839038 |
108 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.54498894 |
109 | Tuberculosis_Homo sapiens_hsa05152 | 0.54453173 |
110 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.53465440 |
111 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.53230776 |
112 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.52188494 |
113 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.51841099 |
114 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.51025233 |
115 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.51003890 |
116 | Tight junction_Homo sapiens_hsa04530 | 0.50694553 |
117 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.50631016 |
118 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.49750487 |
119 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.48962628 |
120 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.48600465 |
121 | Galactose metabolism_Homo sapiens_hsa00052 | 0.46309524 |
122 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.46067330 |
123 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.46060641 |
124 | Shigellosis_Homo sapiens_hsa05131 | 0.45894458 |
125 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.44983980 |
126 | Bladder cancer_Homo sapiens_hsa05219 | 0.43523423 |
127 | Circadian rhythm_Homo sapiens_hsa04710 | 0.43011159 |
128 | Pertussis_Homo sapiens_hsa05133 | 0.42414671 |
129 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.40834401 |
130 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.40387524 |
131 | Salmonella infection_Homo sapiens_hsa05132 | 0.39242973 |
132 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.38930878 |
133 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.36513955 |
134 | Phagosome_Homo sapiens_hsa04145 | 0.36498728 |
135 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.34566896 |
136 | Axon guidance_Homo sapiens_hsa04360 | 0.34353591 |
137 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.32539131 |
138 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.29115625 |
139 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.28788567 |
140 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.28503189 |
141 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.27073643 |
142 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.26512070 |
143 | Endocytosis_Homo sapiens_hsa04144 | 0.21171703 |
144 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.20176197 |
145 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.19309768 |
146 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.17729575 |
147 | Insulin resistance_Homo sapiens_hsa04931 | 0.15270928 |
148 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.14285820 |
149 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.13905216 |
150 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.11922485 |
151 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.10485839 |
152 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.09834630 |